Answer
No, the safety and efficacy of lorlatinib in children under 18 years have not been established, and no data are available.
Sources for this answer
- Lorviqua 25 mg film coated tablets,Pfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 14Document updated
Sources checked